Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7709)
All Articles published online
|
Publishing Process of This Article
|
Feb 14, 2019 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Luo H, Zhang XX, Cao LH, Tan N, Kang Q, Xi HL, Yu M, Xu XY. Serum hepatitis B virus RNA is a predictor of HBeAg seroconversion and virological response with entecavir treatment in chronic hepatitis B patients. World J Gastroenterol 2019; 25(6): 719-728 [PMID: 30783375 DOI: 10.3748/wjg.v25.i6.719] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v25/i6/719.htm |
| Number | Citing Articles |
| 1 |
Guangjun Song, Ruifeng Yang, Qian Jin, Juan Liu, Huiying Rao, Bo Feng, Yandi Xie. HBV pregenome RNA as a predictor of spontanous HBeAg seroconversion in HBeAg-positive chronic hepatitis B patients. BMC Gastroenterology 2023; 23(1) doi: 10.1186/s12876-023-03023-8
|
| 2 |
Xin Ji, Muye Xia, Bin Zhou, Shi Liu, GuiChan Liao, Shaohang Cai, Xiaoyong Zhang, Jie Peng. <p>Serum Hepatitis B Virus RNA Levels Predict HBeAg Seroconversion and Virological Response in Chronic Hepatitis B Patients with High Viral Load Treated with Nucleos(t)ide Analog</p>. Infection and Drug Resistance 2020; : 1881 doi: 10.2147/IDR.S252994
|
| 3 |
Hao Luo, Ning Tan, Qian Kang, Jiali Pan, Hongyu Chen, Hongli Xi, Min Yu, Xiaoyuan Xu. Hepatitis B virus pregenomic RNA status can reveal the long‐term prognoses of chronic hepatitis B patients treated with nucleos(t)ide analogues. Journal of Viral Hepatitis 2020; 27(3): 323 doi: 10.1111/jvh.13227
|
| 4 |
Ung Dinh Nguyen, Quyen Le Do, Quynh Anh Nguyen Vu, Nguyet Thi Trieu, Trang Thuy Dao, Nam Van Le, Son Thai Nguyen, Tuyen Tien Hoang, Chinh Trong Nguyen, Thang Hong Nguyen, Dien Van Nguyen, Tho Huu Ho. Selective detection of HBV pre-genomic RNA in chronic hepatitis B patients using a novel RT-PCR assay. Clinical and Experimental Medicine 2023; 23(8): 5281 doi: 10.1007/s10238-023-01162-6
|
| 5 |
Liandong Wu, Zhenggang Yang, Min Zheng. Biogenesis of serum HBV RNA and clinical phenomena of serum HBV RNA in chronic hepatitis B patients before and after receiving nucleos(t)ide analogues therapy. Journal of Viral Hepatitis 2024; 31(5): 255 doi: 10.1111/jvh.13926
|
| 6 |
Xiaomei Wang, Zhongfeng Wang, Xiumei Chi, Ruihong Wu, Qinglong Jin, Hongqin Xu, Xiuzhu Gao, Lei Yu, Yuping Chen, Jia Shang, Longgen Liu, Shuqin Zhang, Yongfang Jiang, Mingxiang Zhang, Qiaoxia Tong, Lunli Zhang, Youwen Tan, Anlin Ma, Shuangsuo Dang, Bin Xu, Zhenjing Jin, Jia Li, Xiaobo Li, Fengmin Lu, Junqi Niu. Efficacy of a combination of HBV RNA and HBeAg in predicting HBeAg seroconversion in patients treated with entecavir for 144 weeks. International Journal of Infectious Diseases 2020; 99: 171 doi: 10.1016/j.ijid.2020.07.031
|
| 7 |
Yachao Tao, Menglan Wang, Juan Liao, Xing Cheng, Min He, Dongmei Zhang, Taoyou Zhou, Jie Chen, Enqiang Chen, Hong Tang. Dynamics of Serum Pregenome RNA in Chronic Hepatitis B Patients Receiving 96-Month Nucleos(t)ide Analog Therapy. Frontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.787770
|
| 8 |
Xiao-qi Yu, Ming-jie Wang, De-min Yu, Pei-zhan Chen, Ming-yu Zhu, Wei Huang, Yue Han, Qi-ming Gong, Xin-xin Zhang, Yi-Wei Tang. Comparison of Serum Hepatitis B Virus RNA Levels and Quasispecies Evolution Patterns between Entecavir and Pegylated-Interferon Mono-treatment in Chronic Hepatitis B Patients. Journal of Clinical Microbiology 2020; 58(9) doi: 10.1128/JCM.00075-20
|
| 9 |
Jiali Pan, Jinghang Xu, Hao Luo, Ning Tan, Qian Kang, Hongyu Chen, Ran Cheng, Yifan Han, Yuqing Yang, Xiaoyuan Xu. Factors and virological significance of hepatitis B virus pregenomic RNA status after 5 years of antiviral therapy. International Journal of Infectious Diseases 2021; 105: 418 doi: 10.1016/j.ijid.2021.02.116
|
| 10 |
Xuyang Gong, Zhitao Chen, Xiaoxia Zhang, Yi Zheng, Heng Zhang. Effects of Entecavir on Serum Hepatitis B Virus-DNA, Interferon-γ, and Pregenomic RNA in Patients with Chronic Hepatitis B Virus Infection. Hepatitis Monthly 2023; 23(1) doi: 10.5812/hepatmon-132684
|
| 11 |
Matthias Buechter, Arne Maria Günther, Paul Manka, Guido Gerken, Alisan Kahraman. Factors Positively Correlated with Hepatitis B Surface Antigen Seroconversion in Chronic Hepatitis B. Journal of Personalized Medicine 2024; 14(4): 390 doi: 10.3390/jpm14040390
|
| 12 |
Maximilian Wübbolding, Markus Cornberg, Christoph Höner zu Siederdissen. Evidence-Based Approach to Stopping Oral Antiviral Therapy in Chronic HBV. Current Hepatology Reports 2019; 18(4): 512 doi: 10.1007/s11901-019-00502-z
|
| 13 |
Yang Wang, Hao Liao, Zhongping Deng, Yanna Liu, Dandan Bian, Yan Ren, Guangxin Yu, Yingying Jiang, Li Bai, Shuang Liu, Mei Liu, Li Zhou, Yu Chen, Zhongping Duan, Fengmin Lu, Sujun Zheng. Serum HBV RNA predicts HBeAg clearance and seroconversion in patients with chronic hepatitis B treated with nucleos(t)ide analogues. Journal of Viral Hepatitis 2022; 29(6): 420 doi: 10.1111/jvh.13671
|
| 14 |
Mohube B. Maepa, Ridhwaanah Jacobs, Fiona van den Berg, Patrick Arbuthnot. Recent developments with advancing gene therapy to treat chronic infection with hepatitis B virus. Current Opinion in HIV and AIDS 2020; 15(3): 200 doi: 10.1097/COH.0000000000000623
|
| 15 |
Yayun Liu, Wei Liao, Aijing Xu, Wei Yin, Jiao Yu, WenHan Fan, Jianya Xue, Xuesong Liang. Early serum HBV RNA combined with HBsAg response can predict HBeAg seroconversation in patients on Entecavir therapy (ClinicalTrials.gov (NCT03909191)). Journal of Infection 2022; 84(4): e10 doi: 10.1016/j.jinf.2022.01.035
|